Richard Barron - Concepedia

Author

Richard Barron

Also Known As

H Andrae, R Barron, R L Barron, R. Barron, R. L. Barron, R.L. Barron, Rebecca L Barron, Richard Barron, Richard L Barron, Richard L. Barron

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Optum (United States)Duke University Duke Medical Center Fred Hutch Cancer Center

About

Richard Barron is an author at Amgen (United States) specializing in medicine, outcomes research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	650
2	Public Health	5	5	195
3	Health Sciences	2	2	183
4	Emergency Medicine	2	2	119
5	Management	1	1	36

Richard Barron

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices Neelima Denduluri, Debra A. Patt, Yunfei Wang, Journal of the National Comprehensive Cancer Network	2015	139
Repeated Treatments With Botulinum Toxin Type A Produce Sustained Decreases in the Limitations Associated With Focal Upper-Limb Poststroke Spasticity for Caregivers and Patients Elie P. Elovic, Allison Brashear, Darryl Kaelin, Archives of Physical Medicine and Rehabilitation Limitations AssociatedMotor ControlRehabilitationNeurologyCerebral Palsy	2008	119
Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence Brigitte Schurch, P. Denys, Chris M Kozma, European Urology UrologyVoiding DysfunctionBotulinum Toxin ANeurogenic Urinary IncontinenceFemale Urology	2007	106
Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings Derek Weycker, Richard Barron, Alex Kartashov, Journal of Oncology Pharmacy Practice	2013	88
Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States Emily Durden, Lionel Pinto, Lorena López-González, Archives of Osteoporosis	2017	87
A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia Brian Dulisse, Xiaoyan Li, Julie Gayle, Journal of Medical Economics Family MedicineCancer ManagementPrognosisCancer RegistrationCancer Patients	2013	83
Chemotherapy Dose Intensity and Overall Survival Among Patients With Advanced Breast or Ovarian Cancer Neelima Denduluri, Gary H. Lyman, Yunfei Wang, Clinical Breast Cancer	2018	81
Evaluating Use Patterns of and Adherence to Medications for Benign Prostatic Hyperplasia Michael B. Nichol, Tara K. Knight, Joanne Wu, The Journal of Urology	2009	66
Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States Gary H. Lyman, Richard Barron, Robert W. Dubois Current Medical Research and Opinion	2008	65
Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the united states Gary H. Lyman, Richard Barron, Robert W. Dubois Clinical Therapeutics Breast OncologyOncologyHealth EconomicsCancer ManagementOutcomes Research	2009	64

Page 1